Topics covered: Orthopedics and Cardiovascular Medical Devices, Medtech Tax Affects Earnings, Innovation Counters Pricing Pressure, Chinese Low Penetration Rate
Companies covered: Zimmer Holdings, Inc. (NYSE:ZMH), Volcano Corporation (NASDAQ:VOLC), Stryker Corporation (NYSE:SYK), St. Jude Medical, Inc. (NYSE:STJ), Insulet Corporation (NASDAQ:PODD), Medtronic, Inc. (NYSE:MDT), Johnson & Johnson (NYSE:JNJ), Edwards Lifesciences Corporation (NYSE:EW), DexCom, Inc. (NASDAQ:DXCM), Cyberonics, Inc. (NASDAQ:CYBX), Boston Scientific Corporation (NYSE:BSX), Wright Medical Group, Inc. (NASDAQ:WMGI), Symmetry Medical, Inc., NuVasive, Inc. (NASDAQ:NUVA), MAKO Surgical Corp., Baxter International Inc. (NYSE:BAX), ABIOMED, Inc. (NASDAQ:ABMD), Cooper Companies, Inc. (The) (NYSE:COO), Covidien Ltd. (NYSE:COV), Abbott Laboratories (NYSE:ABT), NxStage Medical, Inc. (NASDAQ:NXTM), Siemens AG (OTCMKTS:SIEGY), Koninklijke Philips N.V. (NYSE:PHG), Mindray Medical International Limited (NYSE:MR), General Electric Company (NYSE:GE), FedEx Corporation (NYSE:FDX), Cardica, Inc. (NASDAQ:CRDC)
